Dr. Reddy's announces the launch of Docetaxel Injection USP in US market
On 21 November 2014
Dr Reddys Laboratories announced that it has launched Docetaxel Injection USP 20 mg/ mL and 80 mg/ 4 mL, a therapeutic equivalent of generic version of TAXOTERA (docetaxel Injection) in the US market on 21 November 2014. Dr Reddys ANDA is approved by the United States Food & Drug Administration (USFDA).Powered by Capital Market - Live News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 24 2014 | 11:35 AM IST